Mylan (MYL +1.9%) gets a bump higher after the generic-drug maker raised its FY12 earnings outlook earlier today. It now expects to earn between $2.45 - $2.55 per share. Street consensus is for an EPS of $2.42. The company also outlined plans to repurchase up to $500M in stock in a bid to increase shareholder value.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Mon, 5:20PM)
at Nasdaq.com (Mon, 8:42AM)
at Zacks.com (Fri, 1:30PM)
at Zacks.com (Fri, 8:33AM)
at Investor's Business Daily (Tue, 2:59PM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs